{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:18:08Z","timestamp":1783189088995,"version":"3.54.6"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"7-8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Testicular cancer is the most common cause of cancer in the U.S. male active duty population. Advancements in surgical and chemotherapy approaches have led to a 95% 5-year survival rate across all stages. The United States Preventive Services Task Force recommends against non-symptomatic clinical screening or patient self-examination citing the high survival rate and overall low civilian incidence. We present 2 case reports of active duty individuals who died from complications of testicular cancer. Case 1 was found deceased. At autopsy, a pelvic mass was found disrupting the aorta along with hemoperitoneum. The mass was subsequently identified as a metastatic mixed germ cell tumor. Case 2 presented with orchalgia and a testicular mass, but did not attend to his ordered ultrasound before deployment. He returned to the United States with a &amp;gt;10 cm testis, widespread metastatic disease, and a serum beta-human chorionic gonadotropin (hCG) over 250,000. A non-seminomatous germ cell tumor was presumed, and an orchiectomy was delayed to initiate chemotherapy. He died shortly after therapy was initiated from a pulmonary hemorrhage. In this article, we discuss how unique features of the military population may impact testicular cancer care with evidence from these 2 cases along with suggestions where impactful change can be made.<\/jats:p>","DOI":"10.1093\/milmed\/usaf480","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:57:27Z","timestamp":1758628647000},"page":"e1752-e1755","source":"Crossref","is-referenced-by-count":0,"title":["Insights From Testicular Cancer Deaths in the U.S. Military: Case Reports"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9421-041X","authenticated-orcid":false,"given":"Margaux M","family":"Canevari","sequence":"first","affiliation":[{"name":"Department of Pathology, Indiana University , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-990X","authenticated-orcid":false,"given":"Jeffrey A","family":"Sanford","sequence":"additional","affiliation":[{"name":"Department of Pathology, Blanchfield Army Community Hospital , Fort Campbell, KY 42223,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8871-2396","authenticated-orcid":false,"given":"John C","family":"Walsh","sequence":"additional","affiliation":[{"name":"Naval Construction Group-Two , Gulfport, MS 39501,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany M","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Naval Hospital Camp Pendelton , Camp Pendelton, CA 92055,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8753-5726","authenticated-orcid":false,"given":"Sean","family":"Kern","sequence":"additional","affiliation":[{"name":"Department of Urology, Walter Reed National Military Medical Center , Bethesda, MD 20889,","place":["United States"]},{"name":"Department of Surgery, Murtha Cancer Center, Uniformed Services University , Bethesda, MD 20889,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2026070413275502800_usaf480-B1","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1093\/milmed\/usac297","article-title":"Cancer incidence and etiology in the active duty population of U.S. military","volume":"189","author":"Lovejoy","year":"2022","journal-title":"Mil Med"},{"key":"2026070413275502800_usaf480-B2","author":"American Cancer Society"},{"key":"2026070413275502800_usaf480-B3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/oemed-2022-108628","article-title":"Military occupation and testicular germ cell tumour risk among US Air Force servicemen","volume":"80","author":"Denic-Roberts","year":"2023","journal-title":"Occup Environ Med"},{"key":"2026070413275502800_usaf480-B4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrurol.2012.61","article-title":"Adolescent and adult risk factors for testicular cancer","volume":"9","author":"McGlynn","year":"2012","journal-title":"Nat Rev Urol"},{"key":"2026070413275502800_usaf480-B5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2026070413275502800_usaf480-B6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11255-020-02659-9","article-title":"Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis","volume":"53","author":"Li","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"2026070413275502800_usaf480-B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.55460\/XQO0-ACRL","article-title":"Testicular cancer in an American special forces soldier: a case report","volume":"19","author":"Ho","year":"2019","journal-title":"J Spec Oper Med"},{"key":"2026070413275502800_usaf480-B8","author":"American Cancer Society"},{"key":"2026070413275502800_usaf480-B9","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2026070413275502800_usaf480-B10","volume-title":"Active Duty Military Personnel Master File","author":"U.S. Department of Defense, Defense Manpower Data Center (DMDC)","year":"2000"},{"key":"2026070413275502800_usaf480-B11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3322\/canjclin.43.3.151","article-title":"Detection and treatment of testicular cancer","volume":"43","author":"Richie","year":"1993","journal-title":"CA Cancer J Clin"},{"key":"2026070413275502800_usaf480-B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-154-7-201104050-00006","article-title":"Screening for testicular cancer: U.S. Preventive services task force reaffirmation recommendation statement","volume":"154","author":"U.S. Preventive Services Task Force","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026070413275502800_usaf480-B13","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1158\/1055-9965.EPI-09-0041","article-title":"Cancer incidence in the U.S. military population: comparison with rates from the SEER program","volume":"18","author":"Zhu","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026070413275502800_usaf480-B14","doi-asserted-by":"publisher","first-page":"77007","DOI":"10.1289\/EHP12603","article-title":"A nested case-control study of serum per- and polyfluoroalkyl substances and testicular germ cell tumors among U.S. Air Force Servicemen","volume":"131","author":"Purdue","year":"2023","journal-title":"Environ Health Perspect"},{"key":"2026070413275502800_usaf480-B15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/00001648-199811000-00015","article-title":"Testicular cancer and persian Gulf War service","volume":"9","author":"Knoke","year":"1998","journal-title":"Epidemiology (Fairfax)"},{"key":"2026070413275502800_usaf480-B16","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.3390\/cancers15153944","article-title":"MicroRNA-371a-3p-the novel serum biomarker in testicular germ cell tumors","volume":"15","author":"Nestler","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026070413275502800_usaf480-B17","doi-asserted-by":"publisher","first-page":"605.e9","DOI":"10.1016\/j.urolonc.2017.05.018","article-title":"Testicular cancer: the usage of central review for pathology diagnosis of orchiectomy specimens","volume":"35","author":"Harari","year":"2017","journal-title":"Urol Oncol"},{"key":"2026070413275502800_usaf480-B18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/191\/7-8\/e1752\/64713346\/usaf480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/191\/7-8\/e1752\/64713346\/usaf480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:28:05Z","timestamp":1783186085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/191\/7-8\/e1752\/8287125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":18,"journal-issue":{"issue":"7-8","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usaf480","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2025,10,15]]}}}